RUNX2 and osteonecrosis: In this study, the expression levels of the osteogenic factor RUNX2 were downregulated in both GA-ONFH rats and DXMS-induced BMSCs, and YGY decoction was able to inhibit this decrease and improve osteonecrosis outcomes both in vivo and in vitro.